InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
InfuSystem Holdings (NYSE American: INFU) announced it will release its third quarter 2024 financial results on November 7, 2024, before market open. The company will host a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results. InfuSystem operates through two platforms: Patient Services, providing clinic-to-home healthcare solutions for complex medical equipment, and Device Solutions, supporting direct payer clients with rentals, sales, and biomedical services.
InfuSystem Holdings (NYSE American: INFU) ha annunciato che rilascerà i suoi risultati finanziari per il terzo trimestre 2024 il 7 novembre 2024, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica alle 9:00 ora orientale lo stesso giorno per discutere i risultati. InfuSystem opera attraverso due piattaforme: Servizi per i Pazienti, che fornisce soluzioni sanitarie da clinica a casa per apparecchiature mediche complesse, e Soluzioni per Dispositivi, che supporta clienti diretti con noleggi, vendite e servizi biomedici.
InfuSystem Holdings (NYSE American: INFU) anunció que publicará sus resultados financieros del tercer trimestre de 2024 el 7 de noviembre de 2024, antes de la apertura del mercado. La empresa llevará a cabo una conferencia telefónica a las 9:00 a.m. hora del este el mismo día para discutir los resultados. InfuSystem opera a través de dos plataformas: Servicios al Paciente, que proporciona soluciones de salud de clínica a hogar para equipos médicos complejos, y Soluciones de Dispositivos, que apoya a clientes pagadores directos con alquileres, ventas y servicios biomédicos.
인퓨시스템 홀딩스 (NYSE American: INFU)는 2024년 11월 7일, 시장 개장 전에 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 오전 9시에 결과를 논의하기 위해 컨퍼런스 콜을 개최합니다. 인퓨시스템은 환자 서비스라는 클리닉에서 집으로 제공되는 복잡한 의료 장비를 위한 의료 솔루션과 장비 솔루션이라는 직접 지불 고객을 위한 렌탈, 판매 및 생의학 서비스를 지원하는 두 가지 플랫폼을 통해 운영됩니다.
InfuSystem Holdings (NYSE American: INFU) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 le 7 novembre 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique à 9h00, heure de l'Est, le même jour pour discuter des résultats. InfuSystem fonctionne à travers deux plateformes : Services aux Patients, offrant des solutions de santé de la clinique à domicile pour des équipements médicaux complexes, et Solutions de Dispositifs, soutenant les clients payeurs directs avec des locations, ventes et services biomédicaux.
InfuSystem Holdings (NYSE American: INFU) hat angekündigt, dass die finanziellen Ergebnisse für das dritte Quartal 2024 am 7. November 2024 vor Handelsbeginn veröffentlicht werden. Das Unternehmen wird am selben Tag um 9:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. InfuSystem operiert über zwei Plattformen: Patientenservices, die Klinik-zu-Haus-Gesundheitslösungen für komplexe medizinische Geräte bereitstellt, und Gerätelösungen, die direkte Kostenträgerkunden mit Miet-, Verkaufs- und biomedizinischen Dienstleistungen unterstützt.
- None.
- None.
Investor Conference Call to be held 9:00 a.m. Eastern Time
The Company will also conduct a conference call for all interested parties on Thursday, November 7, 2024 at 9:00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ for the next 90 days or by calling (877) 344-7529 or (412) 317-0088, replay access code 7261158 through Thursday, November 14, 2024.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241031244945/en/
Joe Dorame, Joe Diaz & Robert Blum
Lytham Partners, LLC
602-889-9700
Source: InfuSystem Holdings, Inc.
FAQ
When will InfuSystem (INFU) release Q3 2024 earnings?
What time is InfuSystem's (INFU) Q3 2024 earnings call?
How can investors access InfuSystem's (INFU) Q3 2024 earnings call?
